121 related articles for article (PubMed ID: 2373827)
1. In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: a potential approach for identification of jeopardized myocardium.
Shelton ME; Dence CS; Hwang DR; Herrero P; Welch MJ; Bergmann SR
J Am Coll Cardiol; 1990 Aug; 16(2):477-85. PubMed ID: 2373827
[TBL] [Abstract][Full Text] [Related]
2. Myocardial kinetics of fluorine-18 misonidazole: a marker of hypoxic myocardium.
Shelton ME; Dence CS; Hwang DR; Welch MJ; Bergmann SR
J Nucl Med; 1989 Mar; 30(3):351-8. PubMed ID: 2738664
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography.
Martin GV; Caldwell JH; Graham MM; Grierson JR; Kroll K; Cowan MJ; Lewellen TK; Rasey JS; Casciari JJ; Krohn KA
J Nucl Med; 1992 Dec; 33(12):2202-8. PubMed ID: 1460516
[TBL] [Abstract][Full Text] [Related]
4. Enhanced binding of the hypoxic cell marker [3H]fluoromisonidazole in ischemic myocardium.
Martin GV; Caldwell JH; Rasey JS; Grunbaum Z; Cerqueira M; Krohn KA
J Nucl Med; 1989 Feb; 30(2):194-201. PubMed ID: 2738648
[TBL] [Abstract][Full Text] [Related]
5. Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone).
Lewis JS; Herrero P; Sharp TL; Engelbach JA; Fujibayashi Y; Laforest R; Kovacs A; Gropler RJ; Welch MJ
J Nucl Med; 2002 Nov; 43(11):1557-69. PubMed ID: 12411560
[TBL] [Abstract][Full Text] [Related]
6. Cardiac emission computed tomography: underestimation of regional tracer concentrations due to wall motion abnormalities.
Parodi O; Schelbert HR; Schwaiger M; Hansen H; Selin C; Hoffman EJ
J Comput Assist Tomogr; 1984 Dec; 8(6):1083-92. PubMed ID: 6334106
[TBL] [Abstract][Full Text] [Related]
7. Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia.
Caldwell JH; Revenaugh JR; Martin GV; Johnson PM; Rasey JS; Krohn KA
J Nucl Med; 1995 Sep; 36(9):1633-8. PubMed ID: 7658224
[TBL] [Abstract][Full Text] [Related]
8. Assessment of thallium-201 redistribution versus glucose uptake as predictors of viability after coronary occlusion and reperfusion.
Melin JA; Wijns W; Keyeux A; Gurné O; Cogneau M; Michel C; Bol A; Robert A; Charlier A; Pouleur H
Circulation; 1988 Apr; 77(4):927-34. PubMed ID: 3349587
[TBL] [Abstract][Full Text] [Related]
9. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of salvage of reperfused ischemic myocardium by diltiazem.
Knabb RM; Rosamond TL; Fox KA; Sobel BE; Bergmann SR
J Am Coll Cardiol; 1986 Oct; 8(4):861-71. PubMed ID: 3489747
[TBL] [Abstract][Full Text] [Related]
11. Fluoromisonidazole. A metabolic marker of myocyte hypoxia.
Martin GV; Cerqueira MD; Caldwell JH; Rasey JS; Embree L; Krohn KA
Circ Res; 1990 Jul; 67(1):240-4. PubMed ID: 2364494
[TBL] [Abstract][Full Text] [Related]
12. Characterization of iodovinylmisonidazole as a marker for myocardial hypoxia.
Martin GV; Biskupiak JE; Caldwell JH; Rasey JS; Krohn KA
J Nucl Med; 1993 Jun; 34(6):918-24. PubMed ID: 8509858
[TBL] [Abstract][Full Text] [Related]
13. Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography.
Bergmann SR; Lerch RA; Fox KA; Ludbrook PA; Welch MJ; Ter-Pogossian MM; Sobel BE
Am J Med; 1982 Oct; 73(4):573-81. PubMed ID: 6981998
[TBL] [Abstract][Full Text] [Related]
14. A new 18F-labeled myocardial PET tracer: myocardial uptake after permanent and transient coronary occlusion in rats.
Higuchi T; Nekolla SG; Huisman MM; Reder S; Poethko T; Yu M; Wester HJ; Casebier DS; Robinson SP; Botnar RM; Schwaiger M
J Nucl Med; 2008 Oct; 49(10):1715-22. PubMed ID: 18794259
[TBL] [Abstract][Full Text] [Related]
15. Early recovery of regional performance in salvaged ischemic myocardium following coronary artery occlusion in the dog.
Darsee JR; Kloner RA; Braunwald E
J Clin Invest; 1981 Jul; 68(1):225-39. PubMed ID: 7019244
[TBL] [Abstract][Full Text] [Related]
16. [Relation between myocardial perfusion, myocardial necrosis and residual glucose metabolism as a vitality parameter in the post-ischemic myocardium following coronary reperfusion].
Sochor H
Acta Med Austriaca Suppl; 1989; 39():1-36. PubMed ID: 2787948
[TBL] [Abstract][Full Text] [Related]
17. Myocardial thallium-201 kinetics during coronary occlusion and reperfusion: influence of method of reflow and timing of thallium-201 administration.
Granato JE; Watson DD; Flanagan TL; Gascho JA; Beller GA
Circulation; 1986 Jan; 73(1):150-60. PubMed ID: 3940665
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography demonstrates that coronary sinus retroperfusion can restore regional myocardial perfusion and preserve metabolism.
O'Byrne GT; Nienaber CA; Miyazaki A; Araujo L; Fishbein MC; Corday E; Schelbert HR
J Am Coll Cardiol; 1991 Jul; 18(1):257-70. PubMed ID: 2050930
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of prolonged metabolic abnormalities in reperfused canine myocardium.
Buxton DB; Mody FV; Krivokapich J; Phelps ME; Schelbert HR
Circulation; 1992 May; 85(5):1842-56. PubMed ID: 1572040
[TBL] [Abstract][Full Text] [Related]
20. Characterization of fluoromisonidazole binding in stroke.
Spratt NJ; Ackerman U; Tochon-Danguy HJ; Donnan GA; Howells DW
Stroke; 2006 Jul; 37(7):1862-7. PubMed ID: 16763190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
